NOELIA
DIAZ MORALES
Investigadora hasta 2021
Sandra
Lopez Domenech
Publicaciones en las que colabora con Sandra Lopez Domenech (13)
2022
2019
-
Dietary weight loss intervention improves subclinical atherosclerosis and oxidative stress markers in leukocytes of obese humans
International Journal of Obesity, Vol. 43, Núm. 11, pp. 2200-2209
2018
-
Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation
Cellular Physiology and Biochemistry, Vol. 50, Núm. 3, pp. 1015-1028
-
Mitochondrial DNA haplogroup JT is related to impaired glycaemic control and renal function in type 2 diabetic patients
Journal of Clinical Medicine, Vol. 7, Núm. 8
-
Obesity impairs leukocyte-endothelium cell interactions and oxidative stress in humans
European Journal of Clinical Investigation, Vol. 48, Núm. 8
-
The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes
Scientific Reports, Vol. 8, Núm. 1
2017
-
Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?
Antioxidants and Redox Signaling, Vol. 27, Núm. 17, pp. 1439-1445
-
Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals
International Journal of Obesity, Vol. 41, Núm. 10, pp. 1556-1563
2016
-
Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients?
Antioxidants and Redox Signaling, Vol. 25, Núm. 2, pp. 108-115
-
Atherosclerosis, Mitochondrial Dysfunction and Oxidative Stress: Mitochondria-Targeted Anti-oxidants as Potential Therapy
Frontiers in Medicinal Chemistry (Bentham Science Publishers), pp. 96-135
-
Role of oxidative stress and mitochondrial dysfunction in skeletal muscle in type 2 diabetic patients
Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2650-2656
2015
-
Is Autophagy Altered in the Leukocytes of Type 2 Diabetic Patients?
Antioxidants and Redox Signaling, Vol. 23, Núm. 13, pp. 1050-1056
-
Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients
Atherosclerosis, Vol. 242, Núm. 1, pp. 167-173